Increased risk of new-onset type 2 diabetes in people with chronic kidney disease
- 86 Downloads
This study investigated whether people with chronic kidney disease (CKD) are at the risk of new-onset type 2 diabetes.
A cohort comprising 16,624 people with CKD, and an age- and sex-matched control cohort of 66,496 persons without any clinical kidney disease were identified from the Taiwan National Health Insurance Database during the period of 2000–2010. Both cohorts were followed up to 2011 to evaluate the incidence and hazard ratio (HR) of developing new-onset type 2 diabetes. Diseases were identified based on diagnosis coding.
The incidence of type 2 diabetes was 1.51-fold higher in the CKD cohort than in the control cohort (16.9 versus 11.2 per 1,000 person-years) with an adjusted hazard ratio of 1.17 (95% confidence interval, (CI)1.10–1.24). In the multivariate Cox regression model considering the competing-risk death, the adjusted subhazard ratio of type 2 diabetes was 1.30 (95% CI1.22–1.38) for the CKD cohort compared to the control cohort.
People with CKD patients are at an increased risk of developing new-onset type 2 diabetes. Close surveillance for diabetes should be considered for these people.
KeywordsDiabetes Incidence Insulin resistance Chronic kidney disease
This study is supported in part by Grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), Children’s Hospital of China Medical University (DMR-105-041), China Medical University Hospital (DMR-107-026, DMR-107-176, and DMR-108-111), Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10601010036), Taiwan Clinical Trial Consortium for Stroke (MOST 107-2321-B-039-004), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
For this type of study, formal consent is not required.
- 1.Renal Data System US, USRDS 2014 Annual Data Report: Atlas of Chronic Kidney and End-Stage Renal Disease in the United States, National Institue of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MDGoogle Scholar
- 4.Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D, Group MS (2005) Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 16(4):1091–1098. https://doi.org/10.1681/ASN.2004090742 CrossRefPubMedGoogle Scholar
- 8.Cheng HT, Huang JW, Chiang CK, Yen CJ, Hung KY, Wu KD (2012) Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. J Clin Endocrinol Metab 97(4):1268–1276. https://doi.org/10.1210/jc.2011-2658 CrossRefPubMedGoogle Scholar
- 9.Nerpin E, Riserus U, Ingelsson E, Sundstrom J, Jobs M, Larsson A, Basu S, Arnlov J (2008) Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 31(8):1550–1555. https://doi.org/10.2337/dc08-0369 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Pham H, Robinson-Cohen C, Biggs ML, Ix JH, Mukamal KJ, Fried LF, Kestenbaum B, Siscovick DS, de Boer IH (2012) Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clin J Am Soc Nephrol 7(4):588–594. https://doi.org/10.2215/CJN.11861111 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Huxley R, James WP, Barzi F, Patel JV, Lear SA, Suriyawongpaisal P, Janus E, Caterson I, Zimmet P, Prabhakaran D, Reddy S, Woodward M, Obesity in Asia C (2008) Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 9(Suppl 1):53–61. https://doi.org/10.1111/j.1467-789X.2007.00439.x CrossRefPubMedGoogle Scholar